Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

A new study shows that the body’s early immune response, not the virus itself, often determines how severe a rhinovirus cold ...

This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the fifth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

Learn how a newly discovered virus disrupts its host’s nucleus in ways that echo how complex cells may have formed billions ...

Across the world, only a few dozen people appear to carry a genetic glitch that lets them brush off viruses that flatten ...

Ushikuvirus is a newly identified giant virus that infects amoebas, adding to a growing group of oversized viruses that scientists believe may have played an important role in the emergence of complex ...

A new study, by Dr. Michael Martynowycz from the Hauptman-Woodward Medical Research Institute (HWI), and researchers at UCLA, and HHMI, reveals how viruses hijack cellular condensates to assemble and ...